Effect of Chaerophyllum macropodum extracts on Trichomonas vaginalis in vitro

Autor: Jabari Maryam, Asghari Gholamreza, Ghanadian Mostafa, Jafari Azizullah, Yousefi Hosseiail, Jafari Rasool, Sharafi Seyedeh Marayam, Yousofi Darani Hossein

Publikováno v: Journal of HerbMed Pharmacology, Vol 4, Iss 2, Pp 61-64 (2015)

Introduction: Trichomonas vaginalis (T. vaginalis) is a protozoan parasite causing trichomoniasis or trichomonal vaginitis. The infection is considered as non-viral sexually transmitted disease (STD). Metronidazole and Tinidazole are now the drugs of

Externí odkaz: https://doaj.org/article/35195b06c04c431cadf33591658b3450

Developing an 8-Week, Tele-Education Weight Control and Exercise Programme, and Evaluating Its Effects on Weight and Pain Reduction in Patients With Obesity and Knee Osteoarthritis: A Double-Blinded Randomised Clinical Trial.

Autor: Khazaei R; Sports and Exercise Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Maleklou F; Sports and Exercise Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Bodaghabadi Z; Sports and Exercise Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Tavana MM; Sports and Exercise Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Kluzek S; Queen's Medical Centre, University of Nottingham, Nottingham, UK., Sharafi SE; Psychosomatic Research Center, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran., Feshki MS; Consultant in Child and Adolescent Psychiatry, NHS, Newcastle upon Tyne, UK., Alizadeh Z; Sports and Exercise Medicine Department, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.

Publikováno v: Musculoskeletal care [Musculoskeletal Care] 2024 Sep; Vol. 22 (3), pp. e1926.

The prevalence of violence and its association with mental health among the Iranian population in one year after the outbreak of COVID-19 disease.

Autor: Kamali K; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran., Maleki A; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran., Yazdi SAB; Department of Mental Health, Ministry of Health and Medical Education of Iran, Tehran, Iran., Faghihzadeh E; Department of Epidemiology and Biostatistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., Hoseinzade Z; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran., Hajibabaei M; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Sharafi SE; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Noorbala AA; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. noorbala1@tums.ac.ir.; Department of Psychiatry, Psychiatry and Psychology Research Center, Tehran University of Medical Sciences, Roozbeh Hospital, South Kargar AV., Tehran, 13185/1741, Iran. noorbala1@tums.ac.ir.

Publikováno v: BMC psychiatry [BMC Psychiatry] 2023 Jan 13; Vol. 23 (1), pp. 33. Date of Electronic Publication: 2023 Jan 13.

Survey on Mental Health Status in Iranian Population Aged 15 and Above One Year after the Outbreak of COVID-19 Disease: A Population-Based Study.

Autor: Noorbala AA; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Maleki A; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran., Bagheri Yazdi SA; Department of Mental Health, Ministry of Health and Medical Education of Iran, Tehran, Iran., Faghihzadeh E; Department of Epidemiology and Biostatistics, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran., Hoseinzadeh Z; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran., Hajibabaei M; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Sharafi SE; Psychosomatic Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran., Kamali K; Social Determinants of Health Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.

Publikováno v: Archives of Iranian medicine [Arch Iran Med] 2022 Apr 01; Vol. 25 (4), pp. 201-208. Date of Electronic Publication: 2022 Apr 01.

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice.

Autor: Jazaeri A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: aajazaeri@mdanderson.org., Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Frumovitz MM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Soliman PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Shafer A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Cutrera JJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Klinger M; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Sharafi SE; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Johnson CAL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Villanueva VF; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Hinchcliff EM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Dickens A; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Cain KE; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Anderson JE; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Lu KH; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America., Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2018 Nov; Vol. 151 (2), pp. 374-380. Date of Electronic Publication: 2018 Sep 10.